文献速递脊柱关节炎

脊柱关节炎转诊策略的人群表现:全国性流行病学研究

Performance of referral strategies for spondyloarthritis: a population-based nationwide study.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

改良ASAS转诊策略和EpiReumaPt转诊策略敏感性最高(85%和72%),阴性后验概率最低(0.6%和0.7%)。EpiReumaPt转诊策略在敏感性与阳性预测值间平衡最佳,适用于无实验室和影像数据时的一般人群筛查。

要点

  • 改良ASAS转诊策略敏感性85%,阴性后验概率0.6%,适合排除脊柱关节炎。
  • EpiReumaPt转诊策略敏感性72%,阴性后验概率0.7%,敏感性与阳性预测值平衡最佳。
  • 一般人群中阳性转诊策略的脊柱关节炎阳性预测值范围仅2.2%–7.6%。

核心结论

  • EpiReumaPt转诊策略在无实验室和影像数据时对一般人群脊柱关节炎筛查表现最佳。
  • 改良ASAS转诊策略敏感性最高,阴性后验概率最低。

研究设计与样本

  • 第二阶段由风湿科医生评估阳性筛查者和20%阴性筛查者,最终由三名风湿科医生复核诊断。
  • 共纳入3877名第二阶段参与者,其中92例诊断为脊柱关节炎。

主要发现

  • 脊柱关节炎加权全国患病率为1.6%(95%CI:1.2,2.1)。
  • 改良ASAS转诊策略敏感性85%,EpiReumaPt转诊策略敏感性72%。
  • 阴性时脊柱关节炎后验概率分别为改良ASAS 0.6%、EpiReumaPt 0.7%。
  • 以1.6%患病率为预试概率,阴性筛查使脊柱关节炎概率分别降低63%(ASAS)和56%(EpiReumaPt)。
  • 其他转诊策略降低疾病概率范围为-6.3%至-37.5%,阳性转诊策略的阳性预测值范围为2.2%至7.6%。

关键数值与推荐

  • 改良ASAS转诊策略:敏感性85%,阴性后验概率0.6%。
  • EpiReumaPt转诊策略:敏感性72%,阴性后验概率0.7%。
  • 脊柱关节炎加权全国患病率1.6%(95%CI:1.2,2.1)。

临床怎么用

  • 在无实验室和影像数据时,可优先采用EpiReumaPt转诊策略进行一般人群脊柱关节炎筛查。
  • 改良ASAS转诊策略阴性结果可大幅降低脊柱关节炎概率,适合用于排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the performance of the referral strategy (RS) for SpA of a nationwide epidemiological study (EpiReumaPt), as compared with previously proposed RSs. METHODS: EpiReumaPt was a three-stage national epidemiologic study. In phase one, 10 661 adult participants were randomly selected and screened for rheumatic and musculoskeletal diseases. In the second phase, positive screenings for ⩾1 rheumatic and musculoskeletal disease plus 20% negative screenings were assessed by a rheumatologist. Finally, three rheumatologists revised all the information and defined the final diagnosis. All participants from phase two were included. Thirteen RS were tested against the SpA diagnosis using several metrics, including sensitivity, specificity, the post-test probability of SpA given a positive RS (positive predictive value) and given a negative RS (1 - negative predictive value). RESULTS: From the total 3877 participants, 92 received a SpA diagnosis [weighted national prevalence: 1.6% (95% confidence interval: 1.2, 2.1)]. Modified versions of the Assessment of SpondyloArthritis international Society-RS and EpiReumaPt-RS were the most sensitive (85% and 72%, respectively) and yielded the lowest post-test probabilities of SpA if negative (0.6% and 0.7%, respectively). Considering the national prevalence (pre-test probability) of SpA (1.6%), a negative screening by these two RSs decreased the probability of SpA substantially (Assessment of SpondyloArthritis international Society: -63%; EpiReumaPt: -56%). Other RSs performed less well in reducing disease probability (range: -6.3%; -37.5%). Overall, the probability of SpA given a positive RS was small (positive predictive value range: 2.2%; 7.6%) and the EpiReumaPt RS yielded the best balance between sensitivity and positive predictive value. CONCLUSION: The proposed EpiReumaPt RS performed the best as a screening tool for SpA in patients from the general population when laboratory and imaging data were not available.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Sepriano AR, Ramiro S, Araújo FC, et al. Performance of referral strategies for spondyloarthritis: a population-based nationwide study. Rheumatology (Oxford). 2019. PMID: 30649551. doi:10.1093/rheumatology/key436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。